Myelodysplastic Syndrome/Acute Myeloid Leukemia Follow-Up Study

Contact: Sara Strom, Ph.D.

Number of Enrolled Cancer Patients/Survivors: 2,000
Years of Diagnoses of Enrolled Cancer Patients/Survivors: 2002
Approximate Years of Follow-up: Mean 6 years
Cancer Sites Represented: Leukemias
Biological Specimens Collected: Blood
Germline DNA
Treatment Outcome Measures: Physician/Medical Record Reported
  • Cancer Recurrence
  • Death
  • Late Medical Event
  • Cancer Recurrence
  • Death
Co-morbidities at Study Entry: None
Lifestyle Factors: Smoking
Alcohol Use
Physical Activity
Body Mass Index
Treatment Data: Surgery
Hormonal Therapy
Bone Marrow/Stem Cell Transplant
Treatment Data Assessed By: Electronic Record
Chart Abstraction
Patient Reported Questionnaire
Is the study open to collaboration? Yes

Return to Top